- Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
CVS: 4 Approaches to Reduce The Cost Impact of Gene Therapies
- While the life-changing and life-saving potential of gene therapies is tremendously exciting, finding ways to pay for these treatments is a significant challenge for families and payors.- With prices for a single treatment as high as $2 million, many employers are struggling to find ways to offer coverage without bankrupting their health plans, or even their companies.- Newly released CVS Health white paper outlines four key approaches that health plans and employers can utilize to reduce the
Read More
Duke, Deerfield Management Form Four Points Innovation to Invest Up $130M in Drug Discovery
- Duke University and Deerfield Management Company form major translation research collaboration company, Four Points Innovation. - Deerfield will invest up to $130 million of initial funding to accelerate drug discovery at Duke for 10 years. Duke University and Deerfield Management Company, a healthcare investment firm has announced the creation of a major translational research collaboration company, Four Points Innovation. Spearheaded by Duke University’s Office of Licensing &
Read More
Alphabet’s Verily, Emory Healthcare Partner to Leverage Big Data to Optimize Medication & Lab Ordering Patterns
- Alphabet’s Verily is partnering with Atlanta, GA-based Emory Healthcare on deep analysis of medications and lab ordering patterns for improved diagnosis and treatment at the point of care. - Verily is a subsidiary of Alphabet focused on life sciences and healthcare that develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage diseaseVerily, an Alphabet company is partnering with Emory Healthcare to deploy new solutions to help
Read More
Verantos Awarded NIH Grant to Fund Clinical Phenotyping in Real-World Evidence
- Verantos has been awarded a grant from the National Institutes of Health (NIH) to fund advanced clinical phenotyping in real-world evidence (RWE) studies.- Grant number R44TR002437 ties directly to the 21st Century Cures Act's national goals of increasing the use of RWE to refine the standard of care and create a more tailored approach to therapy.Verantos, a Palo Alto, CA-based provider of regulatory-grade real-world evidence (RWE) studies, today announced that it has received a grant from the
Read More
Cleveland Clinic Awarded $12M to Study Link Between Gut Microbes & Heart Disease
- Stanley Hazen, M.D., Ph.D., director of Cleveland Clinic's Center for Microbiome & Human Health and his team has been awarded a $12M NIH grant to study the link between gut microbes, heart disease.
- The new research program will consist of three specialized projects and four supporting cores focused on the gut microbiome.
TheNational Institutes of Health (NIH) has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and
Read More
Industry 4.0 in Life Sciences: A “5C” Point of View
McKinsey & Company describes Industry 4.0 as the next phase in the digitization of the manufacturing sector that is being driven by four disruptions: the astonishing rise in data volumes, computational power and connectivity, especially new low-power wide-area networks; the emergence of analytics and business intelligence capabilities; the new forms of human-machine interaction, such as touch interfaces and augmented reality systems; and the improvements in transferring digital instructions
Read More
GenapSys Nabs $90M to Commercialize Its Breakthrough Electronic Gene Sequencer
- GenapSys launches first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital. - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size.- The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand
Read More
InterSystems, Virtusa Partner to Enhance Patient Data Integration
- InterSystems and Virtusa Corporation partner to enhance the healthcare data integration capabilities of its vLife™ life sciences platform.- The Collaboration will create an advanced platform for healthcare data management, research and analytics.InterSystems, and Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services and solutions have announced their partnership in an effort to drive positive patient outcomes while reducing cost through improved
Read More
Life Image, Graticule Launches Imaging Dataset In AWS Data Exchange
- Life Image and Graticule announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange. - GLIMPS (Graticule Life Image Machine Parsed Set) is a de-identified patient-level data set including a summary of features generated from NLP processing on Life Image data. - The goal of GLIMPS is to provide a cost-effective patient-level snapshot to biopharma data science teams to fuel the necessary discussions about these data, leading
Read More
